pCR3.1-CREM4
(Plasmid
#106459)
-
PurposeCMV promoter with 4 CRE sites mutated, can be used to create a reporter vector
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 106459 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCR3.1
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert name4 CRE sites mutated
-
SpeciesSynthetic
-
Mutation4 CRE sites mutated
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII (unknown if destroyed)
- 3′ cloning site XhoI (unknown if destroyed)
- 5′ sequencing primer CMV-F (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCR3.1-CREM4 was a gift from Georg Weber (Addgene plasmid # 106459 ; http://n2t.net/addgene:106459 ; RRID:Addgene_106459) -
For your References section:
Synergistic activation of the CMV promoter by NF-kappaB P50 and PKG. He B, Weber GF. Biochem Biophys Res Commun. 2004 Aug 13;321(1):13-20. doi: 10.1016/j.bbrc.2004.06.101. 10.1016/j.bbrc.2004.06.101 PubMed 15358208